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Background: Acute glaucoma is a significantly sight-threatening cause of irreversible blindness in the world
characterized by a sudden and substantial intraocular pressure (IOP) increase and subsequent retinal ganglion cell
(RGC) death. This study aims to explore the role of high-mobility group box 1 (HMGB1) in an acute glaucoma
mouse model.
Methods: An acute glaucoma model was induced by a rapid and substantial increase IOP to 70 mmHg for
60 min via anterior chamber punctured and affused with Balance Salt Solution in C57BL/6 mice. Retinal tissue
ischemic damage and loss of RGCs were assessed at 6, 24, 48, 72 h after high IOP treatment, and at 48 h,
group with or without recombinant high-mobility group box 1 (rHMGB1), the HMGB1 inhibitor, glycyrrhizic
acid (GA), and by HE and immunofluorescent staining. The nuclear factor κB (NF-κB) inhibitor, JSH-23, and
caspase-8 inhibitor, Z-IETD-fmk, were injected into vitreous. Reverse transcription and semi-quantitative reverse
transcription polymerase chain reaction (RT-PCR), western blotting, and immunoprecipitation were performed
to evaluate the expression level of nucleotide-binding domain, leucine-rich repeat containing protein 3
(NLRP3), phosphor-NF-κB p65, caspase-8, caspase-1, apoptosis-associated speck-like protein containing a CARD
(ASC), and interleukin-1β (IL-1β).
Results: HMGB1 was increased in ischemic retinal tissue during acute glaucoma as early as 6 h after rapid
IOP elevation. Exogenous HMGB1 exacerbated retinal ischemic damage, RGC loss, and inhibition of
endogenous HMGB1 significantly reduced the severity of disease. HMGB1 significantly induced the elevation
of canonical NLRP3, ASC, caspase-1, and non-canonical capase-8-ASC inflammasome and promoted the
processing of IL-1β. Furthermore, the effect of HMGB1 on NLRP3 inflammasome activation and IL-1β
production was dependent on NF-κB pathway. Thus, HMGB1/caspase-8 pathway promoted the processing of
IL-1β via NF-κB pathway.
Conclusion: The findings of this study identified a novel signaling pathway in which HMGB1, in response to
acutely elevated intraocular pressure, activated the canonical NLRP3 and non-canonical caspase-8
inflammasomes and production of IL-1β during acute glaucoma development. These results provide new
insights to the understanding of the innate response that contributes to pathogenesis of acute glaucoma.
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Glaucoma is the leading cause of permanent vision loss
and irreversible blindness in the world [1]. Acute glau-
coma is caused by a blockage around the trabecular
meshwork allowing buildup of aqueous humor which
results in a rapid increase in intraocular pressure (IOP).
This causes retinal ischemic reperfusion (IR) injury and
retinal ganglion cell (RGC) death [2]. The precise mech-
anisms by which elevated IOP leads to RGC death are
unclear absolutely. High-mobility group box 1 (HMGB1)
protein is an abundant protein that has been shown to
be involved in the pathogenesis of several inflammatory
diseases, including elevated IOP-induced of the inher-
ited glaucoma rat model [3–5]. Once released by nec-
rotic cells in the extracellular milieu, HMGB1 functions
as an alarming or a damage-associated molecular pat-
tern (DAMP) [6, 7]. Several reports have demonstrated
that HMGB1 mediates ischemia-associated inflamma-
tory responses, inducing damage in several IR diseases
[8–11]. Extracellular HMGB1 induces IR inflammatory
responses by directly acting on pattern recognition
receptors, including Toll-like receptors (TLR) 2 and 4
and receptors for advanced glycation end products
(RAGEs) [12–14].
Inflammasomes are intracellular multi-protein cyto-
plasmic complexes that play a central role in several
IR diseases [15–18]. Canonical inflammasomes typically
are multi-protein assemblies formed by the adaptor pro-
tein apoptosis-associated speck-like protein containing a
CARD (ASC), effector caspase-1, and NOD-like receptor
(NLR) family or absent in melanoma 2 (AIM2) [19, 20].
In IR diseases, DAMPs trigger the activation of NLRs
which oligomerize to form a platform for the inflamma-
some, leading to processing of pro IL-1β into its mature
forms via caspase-1 activity [21–23]. Previous reports
have shown nucleotide-binding domain, leucine-rich
repeat containing protein 3 (NLRP3) inflammasome to
be involved in IR injury by promoting the release of
HMGB1 [24, 25]. However, the contribution of HMGB1
to NLRP3 inflammasome activation has not been ex-
plored in IR injury. In order to investigate the effect of
HMGB1 on the activation of NLRP3 inflammasome in
acute glaucoma, we injected exogenous recombinant (r)
HMGB1 and anti-HMGB1 antibody into vitreous in our
acute glaucoma model. We hypothesized that HMGB1
would promote the activation of NLRP3 inflammasome
to mediate retinal ischemic damage and RGC death.
Caspase-8, an initiator caspase with a critical role in
triggering cell apoptosis, is synthesized as a pro-enzyme
and contains a large N-terminal prodomain and a C-
terminal catalytic domain composed of a large and small
subunit separated by a small linker [26]. Our previous
study showed that elevated IOP could induce the acti-
vation of TLR4-caspase-8 pathway which led to retinalischemic damage and RGC death [27]. Since HMGB1 is
the endogenous ligand of TLR4, we therefore hypothe-
sized that HMGB1 may be involved in acute glaucoma
via regulating caspase-8 activation and the process of
IL-1β. Greater understanding of HMGB1 in acute glau-
coma may lead to new therapeutic targets that may halt
the retinal ischemic damage and RGC death.
Methods
Ethics statement
C57BL/6 female mice of 6–8 weeks of age were pur-
chased from the Animal Research Center at Zhongshan
University. The care and use of animals adhered to the
Association for Research in Vision and Ophthalmology
(ARVO) Statement for the use of Animals in Ophthal-
mic and Vision Research and were approved and mo-
nitored by the Institute of Committee of Animal Care of
the Zhongshan Ophthalmic Center (Permit Number:
2011–038).
Establishment of retinal IR model
Mice were anesthetized with 10 ml/kg of 4.3 % chloral
hydrate by intraperitoneal injection. Pupils were dilated
with 1 % tropicamide and corneas were anesthetized
topically with 0.5 % tetracaine hydrochloride eye drops.
Cannulation of the anterior chamber of the right eye
with a 30-gauge needle was performed to increase and
maintain IOP at 70 mmHg by addition of Balance Salt
Solution (Tono-Pen XL; Medtronic Solan, Jacksonville,
FL, USA) for 60 min. The left eye served as a control.
After 60 min, the needle was withdrawn and tobramycin
was applied to avoid bacterial infection. Mice were sacri-
ficed at 6, 24, 48, or 72 h after the procedure.
Intravitreal injection
After induction of IR injury, mice received an intravitreal
injection of recombinant human HMGB1 (1 μg/2 μl;
1690-HM-025, R&D system, Inc., USA), glycyrrhizic acid
(120 μM/2 μl; 50531, Sigma Aldrich, USA), nuclear
factor κB (NF-κB) inhibitor JSH-23 (20 μM/2 μl; J4455,
Sigma Aldrich, USA) , caspase-8 inhibitor Z-IETD-fmk
(20 μM/2 μl; Calbiochem, San Diego, CA, USA), and
PBS (2 μl) vehicle as sham. Mice were sacrificed and
eyes were enucleated 48 h after intravitreal injection.
Histological examination
At the experimental time points, mice were sacrificed
and eyes were enucleated and fixed with 4 % paraformal-
dehyde overnight prior to paraffin embedding. Four 4-
mm-thick sections through the optic nerve of each eye
were cut and stained with hematoxylin and eosin (HE).
Total retinal thickness (from inner to outer limiting
membrane, ILM-OLM) was measured in four adjacent
areas within 1 mm distance to the optic nerve center
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Inc., Thornwood, NY, USA). The samples for confocal
immunofluorescent staining were embedded in an opti-
mal cutting temperature compound (OCT) (Tissue-Tek,
Sakura Finetek USA, Torrance, CA, USA) and stored
at −80 °C for frozen sectioning. The section was made
in 6 μm, blocked and permeated with 5 % BSA-0.5 %
Triton for 1 h at room temperature (RT), and incu-
bated with primary antibody to detect cleaved-caspase-
8 (1:500; #8592, Cell Signaling Technology, Beverly,
MA, USA) at 4 °C overnight. Alexa Fluor 488 donkey
anti-rabbit IgG (A-21206, Invitrogen, Carlsbad, CA,
USA; 1:400) was used to visualize the primary anti-
body. Nuclei were stained with 4′, 6-diamidino-2-phe-
nylindole dihydrochloride (D1306, DAPI, Invitrogen,
Carlsbad, CA, USA). 400× images were collected and
analyzed with a confocal microscope (Carl Zeiss, Inc,
Germany). Statistical analysis was used to compare the
differences among sham, high-mobility group box 1
(rHMGB1), glycyrrhizic acid (GA), IR + PBS, IR+
rHMGB1 and IR + GA groups.
Retinal flat and RGCs quantification
Retinal flat mounts from each group were fixed with
4 % paraformaldehyde for 15 min at RT, rinsed with
PBS three times and blocked and permeated with
20 % BSA-0.5 % Triton-X 100 at RT for 2 h. To
detect RGC markers, flat mounts were incubated
overnight at 4 °C with 1:200 anti-β3-tubulin primary
antibody (#5568, poly rabbit anti β3-tubulin, Cell
Signaling Technology, Beverly, MA, USA). Secondary
antibody was used as frozen section for confocal
microscope. Images were collected and analyzed with
a fluorescent microscope (Carl Zeiss, Inc, Germany).
Four 400× images were obtained from each of the
four quadrants of whole retinal flat mounts. The in-
tensity of fluorescence was analyzed by using Image
Pro Plus (Version 6.0; Media Cybernetics).
Semi-quantitative reverse transcription-polymerase chain
reaction
Total RNA was extracted from retina samples using
Trizol Reagent (Invitrogen, Carlsbad, CA, USA). cDNA
was synthesized with PrimeScript RT Master Mix
(DRR036A, TaKaRa, Dalian, China). PCR was carried
out using a Premix EX Taq Kit (D335A, TaKaRa, Dalian,
China) for 25 cycles of GAPDH and 28–30 cycles of the
other target genes. PCR products were run on a 1.5 %
agarose gel, and gene expression was evaluated by
relative pixel densitometry using Image J software
(National Institutes of Health, USA) after normalization
to GAPDH. The primer sequences are as follows: cas-
pase-8 (forward, 5-ctccgaaaaatgaaggacaga-3; reverse, 5-
cgtgggataggatacagcaga-3), nlrp3 (forward, 5-ggtcctctttaccatgtgcttc-3; reverse, 5-aagtcatgtggctgaagctgta-3), asc
(forward, 5-cttgtcaggggatgaactcaa-3; reverse: 5-ctggtc
cacaaagtgtcctgt-3), il-1beta (forward, 5-tgaaatgccacct
tttgacag-3; reverse, 5-ccacagccacaatgagtgatac-3), gapdh
(forward, 5-aggtcatcccagagctgaacg-3; reverse: 5-cacc
ctgttgctgtagccgtat-3).Western blot analysis
Total and cytoplasmic protein was isolated from retina
samples. Proteins were run on 10 or 12 % polyacryl-
amide gels and transferred to polyvinylidene difluoride
(PVDF) membranes. PVDF membranes were blocked
with 5 % BSA at RT for 60–90 min and incubated over-
night at 4 °C with antigen-specific primary antibodies.
Blots were then incubated with species-specific HRP-
conjugated secondary antibodies for 60 min at RT.
Proteins were visualized by incubation with a chemilu-
minescence substrate kit (ECL Plus; Perkin Elmer Inc.,
Covina, CA, USA). The expression of target proteins
was quantified by Quantity One software (The Discovery
Series) after normalizing to β-actin or GAPDH.
The primary antibodies and dilutions were used as
follows: NLRP3 (1:500; NBP1-77080, Novus, Littleton,
CO, USA, 100 kD), ASC (1:500; 04–147, Millipore,
Temecula, CA, USA, 22 kD), phosphor-NF-κB p65
(1:1000; #3033, Cell Signaling Technology, Beverly,
MA, USA, 65 kD), cleaved caspase-8 (1:500; #8592,
Cell Signaling Technology, Beverly, MA, USA, 18 kD),
caspase-1 (1:200; AB1871, Chemicon, International, Inc.,
USA, pro-caspase-1 45 kD, cleaved-caspase-1 20 kD), IL-
1β (1:500; #8689, Cell Signaling Technology, Beverly,
MA, USA, pro-IL-1β 31 kD, IL-1β 17 kD), β-actin
(1:1000; MAB1445, MultiSciences Biotech, Hangzhou,
China, 45 kD), and GAPDH (#2118, Cell Signaling,
Boston, MA, USA, 36 kD).Immunoprecipitation
Total protein was extracted from each group as stated
above and stored at −80 °C. Incubated with 1 μl anti-
caspase-8 or ASC antibody overnight at 4 °C was 50 μl
of protein. This reaction mixture was then incubated
with protein A magnetic beads (2366538, Millipore,
Temecula, CA, USA) for 30 min at 4 °C. Precipitates
were washed three times with washing buffer and then
eluted from protein A magnetic beads by boiling with
1 × SDS for 10 min at 90–100 °C. Western blot ana-
lysis was used to evaluate the expression of caspase-8
and ASC. Immunoprecipitation antibody, anti-caspase-8
(#8592, Cell Signaling Technology, Beverly, MA), anti-
ASC (sc-22513,Santa Cruz, CA, USA); Western blot
analysis anti-caspase-8 (sc-6134, Santa Cruz, CA, USA),
anti-ASC (ab175449, Abcam), homophytic IgG as the
negative control.
Fig. 1 (See legend on next page.)
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Fig. 1 HMGB1 was actively involved in the pathogenesis of retinal IR injury. a Hematoxylin and eosin staining of retina showed the degeneration
of RGCs and mean thickness decrease of ischemic retinal tissue at different time points after reperfusion. GCL ganglion cell layer, IPL inner
plexiform layer, INL inner nuclear layer, ONL outer nuclear layer, OPL, outer plexiform layer. b Western blot analysis of the cytoplasmic protein
levels of HMGB1 at different time points after reperfusion. Each protein expression level is shown relative to that of controls. c The function of
HMGB1 on the retinal tissue damage in retinal IR injury. The sham procedure was performed without elevating the container in contralateral eyes
as control groups and retinal ischemia reperfusion (IR) injury was observed at 48 h after reperfusion. #P < 0.05 (IR vs IR + rH, IR vs IR + GA). d RGCs
marker β3-tubulin detected RGCs damage by immunofluorescent staining in experimental groups. Data are shown as mean ± SD or percentage.
*P < 0.05, **P < 0.01 vs sham group
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The data were presented as mean ± SD or percentage.
One-way ANOVA, followed by the Dunnett’s multiple
comparison tests and two-way ANOVA were per-
formed using GraphPad Prism software (version 5.0,
GraphPad Software, Inc., San Diego, CA, USA). All
statistical assessments were two-sided, and P values
less than 0.05 were considered statistically significant.
Results
The addition of HMGB1 increased severity of disease,
whereas the inhibition of HMGB1 decreased severity of
acute glaucoma
DAMPs trigger the release of HMGB1 in response to
IR damage [28, 29]. In this study, we sought to deter-
mine the role of HMGB1 in the development of
retinal IR injury caused by elevated IOP radically. In
retinal IR injury models, retinal damage occurs rap-
idly with retinal edema, vacuolar degeneration, and
condensation of nuclear chromatin. HE staining showed
that the retinal thickness was decreased as early as 24 h
after reperfusion (Fig. 1a). Additionally, retinal ischemia
damage rapidly initiated the release of HMGB1 at 6 h
after reperfusion and peaked at 48 h in the protein level
(Fig. 1b). Stimulation of HMGB1 increased the severity
of retinal thickness reduction, and the number of RGC
death was exacerbated, by contrast, the inhibition of
HMGB1 decreased the reduction of retinal thickness and
the number of RGCs death in the retinal IR injury models
(Fig. 1c, d). These results indicated the pivotal role of
HMGB1 in mediating retinal ischemic damage and RGC
death.
HMGB1 promoted caspase-8 inflammasome activation in
acute glaucoma
Caspase-8 has been implicated as an initiator caspase
in death receptor-induced signaling of apoptosis [26].
However, we recently reported a non-apoptotic func-
tion of caspase-8 in mediating inflammatory damage
in retinal IR injury [27]. In our study, we clarified that
exogenous rHMGB1 promoted the protein up-regulation
of cleaved caspase-8 in retinal IR injury. Inhibition of
HMGB1 significantly suppressed the expression of cleaved
caspase-8 in ischemia retinal tissue (Fig. 2a–e). Otherrecent reports have demonstrated novel caspase-8 inflam-
masome activation in response to bacterial or fungal
infection [30, 31]. Therefore, we hypothesized that a non-
canonical caspase-8 inflammasome was involved in the
development of retinal IR injury. Caspase-8 was immu-
noprecipitated with ASC, the adaptor protein in most
inflammasomes, suggesting a role for caspase-8 in ische-
mic retinal tissue (Fig. 2f, g). And rHMGB1 was found to
be relevant to the formation of non-canonical caspase-8
inflammasome (Fig. 2h, i). This finding suggested that a
non-canonical caspase-8 inflammasome was involved in
the mechanisms of retinal IR damage.
HMGB1 regulated the activation of canonical NLRP3
inflammasome in elevated IOP-induced retinal IR injury
Previous studies have reported that NLRP3 inflamma-
some activation promotes the release of HMGB1 and
inflammatory cytokines, such as IL-1β and IL-18, in
several IR diseases [24, 25]. However, the effect of
HMGB1 on NLRP3 inflammasome activation in ret-
inal IR injury has not been examined. Therefore, we
tested the influence of HMGB1 on the activation of
the most characterized inflammasome, NLRP3 inflam-
masome, in retinal IR injury.
Our findings demonstrated that exogenous rHMGB1
promoted the protein up-regulation of NLRP3, ASC
level, and increased caspase-1 processing after reper-
fusion in retinal IR injury (Fig. 3a, c, e, g, i). Inhibition
of HMGB1 significantly suppressed the expression of
NLRP3, ASC, and the maturation of caspase-1 in is-
chemia retinal tissue (Fig. 3b, d, f, h, j). This further
demonstrated the stimulatory effect of HMGB1 on the
activation of NLRP3 inflammasome. Together these
results suggested a novel role for HMGB1 in retinal
IR injury by regulating the activation of NLRP3
inflammasomes.
HMGB1 promoted the processing of IL-1β in elevated
IOP-induced retinal IR injury
The stimulatory nature of HMGB1 on the activation
of NLRP3 and caspase-8 inflammasomes prompted us
to investigate the effect of HMGB1 on the down-
stream cytokines induced by inflammasomes. Our
data demonstrated that the expression of IL-1β was
Fig. 2 HMGB1 promoted non-canonical caspase-8 inflammasome assembled in retinal IR injury. a, b RT-PCR analyzed caspase-8 mRNA
expression. c, d Western blot detected expression of cleaved caspase-8 protein. e rHMGB1 could stimulate the activation of caspase-8 in
RGCs, while inhibition of HMGB1 significantly suppressed the activation by confocal microscope. f, g ASC immunoprecipitated with
caspase-8 and assembled caspase-8-ASC complex in IR model. h, i HMGB1 promoted caspase-8-ASC protein complex formation. Data are
shown as mean ± SD. *P < 0.05, **P < 0.01 vs sham group
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and protein levels (Fig. 4a, c). The processing of
IL-1β was induced or blocked in retinal IR modelfollowing rHMGB1 or inhibition by HMGB1 antibody
intravitreal injection, respectively (Fig. 4b, d). Overall,
these results indicated that HMGB1 release promoted
Fig. 3 (See legend on next page.)
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Fig. 3 HMGB1 promoted the activation of canonical NLRP3 inflammasome in retinal IR injury. The intravitreal injection of exogenous rHMGB1
significantly promoted the mRNA and protein production of NLRP3 (a, c) and ASC (e, g) and activation of caspase-1 (i). Thus, the intravitreal
injection of HMGB1 inhibitor, GA, significantly suppressed the production of NLRP3 (b, d) and ASC (f, h) and activation of caspase-1 (j). Data are
shown as mean ± SD. *P < 0.05, **P < 0.01 vs sham group
Fig. 4 HMGB1 promoted the processing of IL-1β in retinal IR injury. a–d The intravitreal injection of rHMGB1 or HMGB1 inhibitor significantly
enhanced or attenuated the processing of IL-1β in retinal IR injury. Data are shown as mean ± SD. *P < 0.05, **P < 0.01 vs sham group
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Fig. 5 HMGB1 regulated the activation of NLRP3, rather than the activation of caspase-8, via NF-κB pathway. a, b NF-κB was activated in ischemic
retina at the early stage after reperfusion. c, d Intraocular injection rHMGB1 or GA could promote or suppress the production of phosphor-NF-κB
p65. e, f Intravitreal injection of NF-κB p65 inhibitor, JSH-23, significantly reduced the activation of NLRP3 and decreased the processing of IL-1β,
g rather than caspase-8. However, intravitreal injection of caspase-8 inhibitor, Z-IETD-fmk, decreased the production of phosphor-NF-κB p65,
obviously (h). Data are shown as mean ± SD. *P < 0.05, **P < 0.01 vs sham group
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caspase-8 inflammasomes in retinal ischemic damage.
HMGB1 regulated NLRP3 and caspase-8 inflammasomes
activation and IL-1β production via the NF-κB pathway
Next, we aimed to determine the molecular mechanism
by which HMGB1 regulated inflammasome activation
and IL-1β production during retinal IR injury. NF-κB
p65 mRNA and phosphor-NF-κB p65 protein levels were
increased in ischemic retinal tissue (Fig. 5a, b). The level
of phosphor-NF-κB p65 increased or decreased to a
lesser degree in ischemic retinal tissue in response to the
addition of rHMGB1 or HMGB1 inhibitor (Fig. 5c, d),
indicating that HMGB1 activated the nuclear translo-
cation of NF-κB in retinal IR injury. To determine if
HMGB1 regulated inflammasome activation and in-
duced the processing of IL-1β via NF-κB pathway, the
NF-κB p65 inhibitor, JSH-23, was injected into vitreous.
Our results demonstrated that the inhibitor of NF-κB
significantly reduced the activation of NLRP3 (Fig. 5e)
and IL-1β production (Fig. 5f ), rather than caspase-8
(Fig. 5g) in retinal IR injury. However, inhibition of
caspase-8 could significantly suppress the activation of
phosphor-NF-κB (Fig. 5h). All these results demon-
strated that caspase-8 was the upstream of NF-κB;
HMGB1/caspase-8 pathway induced the activation of
NLRP3 and IL-1β production via the NF-κB pathway in
retinal IR injury.
Discussion
Acute glaucoma is a significantly sight-threatening cause
of irreversible blindness in the world characterized by a
sudden and substantial IOP increase and subsequent
RGC death [32, 33]. Acute elevated IOP induced retinal
ischemic inflammatory injury, resulting in RGC death.
We previously demonstrated that TLR4 promoted the
activation of NLRP3 inflammasome which involves in
the inflammatory injury of retinal ischemia [27, 34].
However, the role of endogenous ligand of TLR4,
HMGB1, is not completely understood. Several studies
have reported that NLRP3 promotes the release of
HMGB1 and IL-1β [35, 36]. The object of this study is
to further explore the influence of HMGB1 on inflam-
masome activation.
Several reports have demonstrated that HMGB1 plays
a critical role in ischemic diseases [8–11]. Likewise, we
demonstrated that retinal IR injury triggered theHMGB1 release in retina, accompanying with retinal
damage and RGC death. Increase of HMGB1 in retinal
IR injury is consistent with the study reported by
Dvoriantchikova and Yang [21, 37]. It is well-known
that HMGB1 is an endogenous ligand of TLR4. The
HMGB1-TLR4 pathway mediates certain ischemic dis-
eases [38, 39]. We also previously demonstrated that
TLR4 promotes the retinal ischemic damage via acti-
vating caspase-8 signaling and NLRP1 and NLRP3
inflammasomes and processing IL-1β maturation [27].
This prompted us to further explore the mechanism of
HMGB1 in mediating retinal IR injury. We injected
exogenous HMGB1 or HMGB1 inhibitor into vitreous
of retinal IR mice to investigate the biological function
of HMGB1 in retinal IR injury. We found that HMGB1
significantly promoted cleaved caspase-8 up-regulation
and canonical NLRP3-inflammasome activation, induced
the processing of IL-1β, and resulted retinal injury and
RGC death eventually.
Traditionally, caspase-8 has been primarily viewed as
an initiator of apoptotic cell death activated by recep-
tors of the TNF/NGF family [40–42]. Recently, multiple
non-apoptotic roles of caspase-8 have been reported.
Importantly, caspase-8 has been reported to have a
neuro-inflammatory role [42]. In our previous study, we
demonstrated that activation of caspase-8 was involved
in the inflammation of ischemic retinal damage via pro-
moting microglia activation, NLRP1/NLRP3 inflamma-
some activation, processing of IL-1β, and RGC death
[27]. In the present study, we firstly provided additional
evidence that caspase-8 assembled a novel caspase-8-
ASC inflammasome in retinal IR model. Our observation
showed that non-cannonical caspase-8 inflammasome
was significantly activated in ischemic retinal tissue,
which could also been newly found in fungal infection
[30, 31]. And the formation of novel caspase-8-ASC
inflammasome was relative to the increased HMGB1.
Therefore, our data showed that HMGB1 induced the
processing of IL-1β via both NLRP3-inducing caspase-1
pathway and non-caspase-1 dependent caspase-8 path-
way. Overall, these results indicated that HMGB1 con-
tributed to the inflammation of retinal ischemic damage
by promoting the activation of NLRP3 inflammasome,
the novel caspase-8 inflammasome, and the processing of
IL-1β mediating retinal ischemic damage.
The downstream signaling of all TLR receptors in-
volves three major signaling pathways: mitogen-activated
Chi et al. Journal of Neuroinflammation  (2015) 12:137 Page 11 of 12protein kinases (MAPKs), interferon regulatory factors
(IRFs), and NF-κB [43]. It has been demonstrated that
NF-κB signaling pathway activation was involved in the
production of IL-1β in tissue ischemic damage [44]. In
the present study, we sought to determine the molecular
mechanism of HMGB1 on the processing of IL-1β. Our
findings showed that phosphor-NF-κB p65 expression
was up-regulated in IR model, and NF-κB signaling
pathway activation was associated with increased
HMGB1. We further demonstrated that HMGB1 regu-
lated the activation of NLRP3 and induced the process-
ing of IL-1β in a NF-κB-dependent manner. However,
caspase-8 was in the upstream of NF-κB, regulating its
activation and subsequently the production of IL-1β.
Overall, these results demonstrated that HMGB1 regu-
lated the activation of NLRP3, subsequently the process-
ing of IL-1β via NF-κB-pathway and HMGB1 also
promoted the activation of caspase-8 which subse-
quently regulated the activation of NF-κB and then the
processing of IL-1β.
In conclusion, our present study showed that HMGB1
release was increased in ischemic retinal tissue as early
as 6 h after IR. Exogenous HMGB1 significantly pro-
moted retinal IR injury. We also demonstrated that the
novel caspase-8 inflammasome was activated after IR.
HMGB1 led to the activation of canonical NLRP3 and
non-canonical caspase-8 inflammasomes and the pro-
cessing of IL-1β in retinal IR injury. In addition, HMGB1
regulated the NLRP3 activation and IL-1β maturation in
NF-κB-dependent manner. HMGB1/capase-8 pathway
promoted the activation of NF-κB, which subsequently
induced the processing of IL-1β. Overall, HMGB1 plays
a pivotal role in retinal IR injury through regulating the
NLRP3 and caspase-8 inflammasomes activation and
IL-1β maturation.
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